Sign in

CIK 0000730272 · Large accelerated filer

REPLIGEN CORP

Sign in to watch
Ticker
RGEN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
042729386
Phone
7814499560
Business address
41 SEYON STREET, BUILDING 1, SUITE 100, WALTHAM, MA, 02453
  1. 10-Q Report Quarterly Report
  2. DEF 14A Proxy Proxy Statement
  3. SC 13G Stake Amended Statement of Ownership
  4. S-3 Offering Registration Statement
  5. 10-K Report Annual Report
  6. SC 13G Stake Amended Statement of Ownership
  7. SC 13D Stake Beneficial Ownership Report
  8. 10-Q Report Quarterly Report
  9. SC 13D/A Stake Beneficial Ownership Report
  10. 8-K Event Item 5 · Item 7
  11. 10-Q Report Quarterly Report
  12. 10-Q Report Quarterly Report
  13. 4 Insider Changes in Ownership
  14. 4 Insider Changes in Ownership
  15. 424B3 Offering Prospectus
  16. SC 13D/A Stake Beneficial Ownership Report
  17. S-3 Offering Registration Statement
  18. DEF 14A Proxy Proxy Statement
  19. 10-K Report Annual Report
  20. SC 13D/A Stake Beneficial Ownership Report

Page 68 of 69 · 1,379 filings